v3.26.1
CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS
$ in Thousands
 3 Months Ended
Mar. 31, 2026
USD ($)
Mar. 31, 2025
USD ($)
Cash flows from operating activities:    
Net loss $ (47,122) $ (37,171)
Adjustments to reconcile net loss to net cash used in operating activities:    
Depreciation and amortization 11,219 9,744
Allowance for credit losses and inventory reserves 25 105
Share-based compensation, including restructuring costs 19,734 17,232
Amortization of discount and cost of issuance of debt 670 661
Gain from change in fair value of contingent considerations and acquisition-related holdbacks 1,085 (4,803)
Loss from change in fair value of currency forward contract 637 601
Loss from extinguishment of debt 3,656 0
Amortization of right-of-use assets 824 776
Changes in operating assets and liabilities:    
Accounts receivable (3,115) (10,622)
Inventory (8,476) 2,479
Accounts payable 2,826 (9,985)
Accrued expenses and other current liabilities 980 3,351
Accrued payroll liabilities (3,038) 630
Prepaid, other current and noncurrent assets (1,000) (1,024)
Operating lease liabilities (896) (561)
Other long-term liabilities (135) (414)
Net cash used in operating activities (22,126) (29,001)
Cash flows from investing activities:    
Purchases of property and equipment (3,212) (2,378)
Net cash used in investing activities (3,212) (2,378)
Cash flows from financing activities:    
Proceeds from issuance of debt obligations 170,500 0
Issuance and debt discount costs related to debt obligations (5,387) (50)
Payments on debt obligations (1,200) (2,909)
Repurchase of debt obligations (106,371) 0
Payments on financed software (1,758) (1,748)
Deferred payments on business combination (720) (34)
Proceeds from exercise of stock options 0 1
Net cash provided by (used in) financing activities 55,064 (4,740)
Effect of exchange rate changes on cash and cash equivalents (753) (1,524)
Net decrease in cash and cash equivalents 28,973 (37,643)
Cash, cash equivalents and restricted cash at beginning of period 155,741 284,548
Cash, cash equivalents and restricted cash at end of period 184,714 246,905
Reconciliation of amounts on condensed consolidated balance sheet:    
Cash and cash equivalents 174,433 236,608
Restricted cash 10,281 10,297
Total cash, cash equivalents and restricted cash 184,714 246,905
Supplemental disclosure of cash flow information:    
Cash paid for interest 1,633 185
Supplemental disclosure of non-cash investing and financing activities:    
Purchases of property and equipment, accrued but not paid $ (339) $ (17)